Figure 2.

Kaplan–Meier curves showing primary and secondary endpoint results in the BAMI trial: (A) Primary endpoint—all-cause mortality up to 2 years (full analysis set). (B) Secondary endpoint—cumulative incidence functions for cardiac death up to 2 years (full analysis set). (C) Secondary endpoint—cumulative incidence functions for cardiovascular death or re-hospitalization due to heart failure up to 2 years (full analysis set). (D) Secondary endpoint—cumulative incidence functions for re-hospitalization due to repeat myocardial infarction, revascularization, heart failure, implantable cardioverter-defibrillator, or stroke up to 2 years (full analysis set).